Tunstall forms global partnership with Alzheimer’s Disease International (ADI)

Tunstall Healthcare is proud to form a global partnership with Alzheimer’s Disease International (ADI).

For many years, we have have been creating and using technology to help people affected by dementia live the fullest life possible. With over 55 million people living with dementia worldwide, set to rise to 139 million by 2050, we recognise the crucial role we can play in advancing technology and care services.

We believe that technology has the power to enable people living with dementia to receive the best care without limiting their quality of life and independence.

Emil Peters, Tunstall CEO:

‘I’m incredibly proud that we’ve been able to form this partnership with ADI. Cases of dementia are increasing fast, which is why we’re passionate about using our expertise to advance digital care and health solutions. It’s so important that people have the choice for how and where they live their life, regardless of any physical or neurological health issues. Advancements in healthcare technology has the power to give people that choice.’

Our partnership with ADI will centre around raising education and awareness for our people, partners and stakeholders, as well as fundraising and other support opportunities.

Some things you may not know about dementia:

• Dementia is a collective name for brain syndromes which affect memory, thinking, behaviour and emotion, and is the leading cause of disability and dependency among the elderly

• The worldwide cost of dementia is $1.3trillion

• Across the world, someone is diagnosed with dementia every three seconds

• Early symptoms of dementia can include memory loss, difficulty performing familiar tasks, problems with language and changes in personality

• There is currently no cure for dementia